Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 21 , ISSUE 6 ( 2017 ) > List of Articles

RESEARCH ARTICLE

Continuous renal replacement therapy applications on extracorporeal membrane oxygenation circuit

Ayse Filiz Yetimakman, Murat Tanyildiz, Selman Kesici, Esra Kockuzu, Benan Bayrakci

Keywords : continuous venovenous hemofiltration, extracorporeal membrane oxygenation, renal replacement therapy,Continuous venovenous hemodiafiltration

Citation Information : Yetimakman AF, Tanyildiz M, Kesici S, Kockuzu E, Bayrakci B. Continuous renal replacement therapy applications on extracorporeal membrane oxygenation circuit. Indian J Crit Care Med 2017; 21 (6):355-358.

DOI: 10.4103/ijccm.IJCCM_128_17

License: CC BY-ND 3.0

Published Online: 00-06-2017

Copyright Statement:  Copyright © 2017; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background and Aims: Continuous venovenous hemofiltration or hemodiafiltration is used frequently in pediatric patients, but experience of continuous renal replacement therapy (CRRT) application on extracorporeal membrane oxygenation (ECMO) circuit is still limited. Among several methods used for applying CRRT on ECMO patients, we aim to share our experience on inclusion of a CRRT device in the ECMO circuit which we believe is easier and safer to apply. Materials and Methods: The data were collected on demographics, outcomes, and details of the treatment of ECMO patients who had CRRT. During the study period of 3 years, venous cannula of ECMO circuit before pump was used for CRRT access for both the filter inlet and outlet of CRRT machine to minimize the thromboembolic complications. The common indication for CRRT was fluid overload. Results: CRRT was used in 3.68% of a total number of patients admitted and 43% of patients on ECMO. The patients have undergone renal replacement therapy for periods of time ranging between 24 h and 25 days (260 h mean). The survival rate of this group of patients with multiorgan failure was 33%. Renal recovery occurred in all of the survivors. Complications such as electrolyte imbalance, hypothermia, and bradykinin syndrome were easily managed. Conclusions: Adding a CRRT device on ECMO circuit is a safe and effective technique. The major advantages of this technique are easy to access, applying CRRT without extra anticoagulation process, preventing potential hemodynamic disturbances, and increased clearance of solutes and fluid overload using larger hemofilter.


PDF Share
  1. Bartlett RH, Gazzaniga AB, Jefferies MR, Huxtable RF, Haiduc NJ, Fong SW. Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. Trans Am Soc Artif Intern Organs 1976;22:80-93.
  2. Bartlett RH, Gazzaniga AB, Fong SW, Jefferies MR, Roohk HV, Haiduc N. Extracorporeal membrane oxygenator support for cardiopulmonary failure. Experience in 28 cases. J Thorac Cardiovasc Surg 1977;73:375-86.
  3. Kramer P, Wigger W, Rieger J, Matthaei D, Scheler F. Arteriovenous haemofiltration: A new and simple method for treatment of over-hydrated patients resistant to diuretics. Klin Wochenschr 1977;55:1121-2.
  4. Garzotto F, Zanella M, Ronco C. The evolution of pediatric continuous renal replacement therapy. Nephron Clin Pract 2014;127:172-5.
  5. Villa G, Katz N, Ronco C. Extracorporeal membrane oxygenation and the kidney. Cardiorenal Med 2015;6:50-60.
  6. Askenazi DJ, Selewski DT, Paden ML, Cooper DS, Bridges BC, Zappitelli M, et al. Renal replacement therapy in critically ill patients receiving extracorporeal membrane oxygenation. Clin J Am Soc Nephrol 2012;7:1328-36.
  7. Foland JA, Fortenberry JD, Warshaw BL, Pettignano R, Merritt RK, Heard ML, et al. Fluid overload before continuous hemofiltration and survival in critically ill children: A retrospective analysis. Crit Care Med 2004;32:1771-6.
  8. Hoover NG, Heard M, Reid C, Wagoner S, Rogers K, Foland J, et al. Enhanced fluid management with continuous venovenous hemofiltration in pediatric respiratory failure patients receiving extracorporeal membrane oxygenation support. Intensive Care Med 2008;34:2241-7.
  9. Bellomo R, Ronco C. Continuous versus intermittent renal replacement therapy in the Intensive Care Unit. Kidney Int Suppl 1998;66:S125-8.
  10. Chen H, Yu RG, Yin NN, Zhou JX. Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: A systematic review. Crit Care 2014;18:675.
  11. Santiago MJ, Sánchez A, López-Herce J, Pérez R, del Castillo J, Urbano J, et al. The use of continuous renal replacement therapy in series with extracorporeal membrane oxygenation. Kidney Int 2009;76:1289-92.
  12. Ricci Z, Ronco C, Picardo S. CRRT in series with extracorporeal membrane oxygenation in pediatric patients. Kidney Int 2010;77:469-70.
  13. Clark WR, Ronco C. Determinants of haemodialyser performance and the potential effect on clinical outcome. Nephrol Dial Transplant 2001;16 Suppl 5:56-60.
  14. Henderson L. Biophysics of ultrafiltration and hemofiltration. In: Jacobs C, Kjellstrand C, Koch K, Winchester J, editors. Replacement of Renal Function by Dialysis. 4th ed. Dordrecht: Kluwer Academic Publishers; 1996. p. 114-45.
  15. Goldstein SL, Currier H, Graf CD, Cosio CC, Brewer ED, Sachdeva R. Outcome in children receiving continuous venovenous hemofiltration. Pediatrics 2001;107:1309-12.
  16. Shaheen IS, Harvey B, Watson AR, Pandya HC, Mayer A, Thomas D. Continuous venovenous hemofiltration with or without extracorporeal membrane oxygenation in children. Pediatr Crit Care Med 2007;8:362-5.
  17. Goldstein SL, Somers MJ, Baum MA, Symons JM, Brophy PD, Blowey D, et al. Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int 2005;67:653-8.
  18. Bunchman TE, McBryde KD, Mottes TE, Gardner JJ, Maxvold NJ, Brophy PD. Pediatric acute renal failure: Outcome by modality and disease. Pediatr Nephrol 2001;16:1067-71.
  19. Paden ML, Warshaw BL, Heard ML, Fortenberry JD. Recovery of renal function and survival after continuous renal replacement therapy during extracorporeal membrane oxygenation. Pediatr Crit Care Med 2011;12:153-8.
  20. Meyer RJ, Brophy PD, Bunchman TE, Annich GM, Maxvold NJ, Mottes TA, et al. Survival and renal function in pediatric patients following extracorporeal life support with hemofiltration. Pediatr Crit Care Med 2001;2:238-42.
  21. Brophy PD, Mottes TA, Kudelka TL, McBryde KD, Gardner JJ, Maxvold NJ, et al. AN-69 membrane reactions are pH-dependent and preventable. Am J Kidney Dis 2001;38:173-8.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.